| 1 |
Use of a Vaginal Ring Containing Dapivirine for HIV-1 Prevention in Women
Jared M. Baeten et al. · New England Journal of Medicine
Open access |
22 Feb 2016 |
774 |
| 2 |
Cabotegravir for the prevention of HIV-1 in women: results from HPTN 084, a phase 3, randomised clinical trial
Sinéad Delany‐Moretlwe et al. · The Lancet
Open access109 authors |
Apr 2022 |
584 |
| 3 |
Four-Month Rifapentine Regimens with or without Moxifloxacin for Tuberculosis
Susan E. Dorman et al. · New England Journal of Medicine
Open access |
5 May 2021 |
575 |
| 4 |
Research priorities for an HIV cure: International AIDS Society Global Scientific Strategy 2021
Steven G. Deeks et al. · Nature Medicine
Open access |
30 Nov 2021 |
386 |
| 5 |
Using price distributions to estimate search costs
HAN PING HONG, Matthew Shum · The RAND Journal of Economics
|
Jun 2006 |
352 |
| 6 |
Benefits and Risks of Antiretroviral Therapy for Perinatal HIV Prevention
Mary Glenn Fowler et al. · New England Journal of Medicine
Open access |
2 Nov 2016 |
351 |
| 7 |
Evaluation of Tuberculosis Diagnostics in Children: 1. Proposed Clinical Case Definitions for Classification of Intrathoracic Tuberculosis Disease. Consensus From an Expert Panel
Stephen M. Graham et al. · The Journal of Infectious Diseases
Open access |
24 Mar 2012 |
330 |
| 8 |
Rapid Diagnosis of Tuberculosis with the Xpert MTB/RIF Assay in High Burden Countries: A Cost-Effectiveness Analysis
Anna Vassall, Sanne Christine van Kampen, Hojoon Sohn et al. · PLoS Medicine
Open access |
8 Nov 2011 |
316 |
| 9 |
Substitution of Moxifloxacin for Isoniazid during Intensive Phase Treatment of Pulmonary Tuberculosis
Susan E. Dorman, John L. Johnson, STEFAN V. GOLDBERG et al. · American Journal of Respiratory and Critical Care Medicine
|
30 Apr 2009 |
267 |
| 10 |
Antiretroviral Treatment for Children with Peripartum Nevirapine Exposure
Paul E Palumbo, Jane C. Lindsey, Michael D. Hughes et al. · New England Journal of Medicine
Open access |
13 Oct 2010 |
221 |
| 11 |
Prevention of HIV-1 Transmission Through Breastfeeding: Efficacy and Safety of Maternal Antiretroviral Therapy Versus Infant Nevirapine Prophylaxis for Duration of Breastfeeding in HIV-1-Infected Women With High CD4 Cell Count (IMPAACT PROMISE): A Randomized, Open-Label, Clinical Trial
Patricia Michele Flynn et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes
Open access |
12 Dec 2017 |
220 |
| 12 |
Indirect effects of COVID-19 on maternal, neonatal, child, sexual and reproductive health services in Kampala, Uganda
Jessica Florence Burt, Joseph Ouma, Lawrence Lubyayi et al. · BMJ Global Health
Open access |
Aug 2021 |
201 |
| 13 |
MTN-001: Randomized Pharmacokinetic Cross-Over Study Comparing Tenofovir Vaginal Gel and Oral Tablets in Vaginal Tissue and Other Compartments
Craig W. Hendrix, Beatrice A. Chen, Vijayanand Guddera et al. · PLoS ONE
Open access |
30 Jan 2013 |
200 |
| 14 |
HIV-Associated Pneumocystis Pneumonia
Laurence Huang, Adithya Cattamanchi, J. Lucian Davis et al. · Proceedings of the American Thoracic Society
Open access |
Jun 2011 |
193 |
| 15 |
Nevirapine versus Ritonavir-Boosted Lopinavir for HIV-Infected Children
Avy Violari, Jane C. Lindsey, Michael D. Hughes et al. · New England Journal of Medicine
Open access |
21 Jun 2012 |
184 |
| 16 |
Patterns of antibiotic use, pathogens, and prediction of mortality in hospitalized neonates and young infants with sepsis: A global neonatal sepsis observational cohort study (NeoOBS)
Neal Russell et al. · PLoS Medicine
Open access |
8 Jun 2023 |
180 |
| 17 |
Shorter Treatment for Nonsevere Tuberculosis in African and Indian Children
Anna Turkova et al. · White Rose Research Online (University of Leeds, The University of Sheffield, University of York)
Open access |
10 Mar 2022 |
173 |
| 18 |
Bacterial Factors That Predict Relapse after Tuberculosis Therapy
Roberto Colangeli, Hannah Jedrey, Soyeon Kim et al. · New England Journal of Medicine
Open access |
29 Aug 2018 |
161 |
| 19 |
Longitudinal Antiretroviral Adherence in HIV+ Ugandan Parents and Their Children Initiating HAART in the MTCT-Plus Family Treatment Model: Role of Depression in Declining Adherence Over Time
Jayne Byakika-Tusiime, Johanna Tayloe Crane, Jessica H. Oyugi et al. · AIDS and Behavior
Open access |
19 Mar 2009 |
161 |
| 20 |
Leveraging Rapid Community-Based HIV Testing Campaigns for Non-Communicable Diseases in Rural Uganda
Gabriel Chamie, Dalsone Kwarisiima, Tamara D. Clark et al. · PLoS ONE
Open access |
20 Aug 2012 |
151 |
| 21 |
Bedaquiline, moxifloxacin, pretomanid, and pyrazinamide during the first 8 weeks of treatment of patients with drug-susceptible or drug-resistant pulmonary tuberculosis: a multicentre, open-label, partially randomised, phase 2b trial
Conor Tweed, Rodney Dawson, Divan Aristo Burger et al. · The Lancet Respiratory Medicine
Open access |
12 Nov 2019 |
150 |
| 22 |
Efficacy and safety of an extended nevirapine regimen in infant children of breastfeeding mothers with HIV-1 infection for prevention of postnatal HIV-1 transmission (HPTN 046): a randomised, double-blind, placebo-controlled trial
Hoosen Mohamed Coovadia et al. · The Lancet
Open access |
23 Dec 2011 |
142 |
| 23 |
Clinical risk factors of adverse outcomes among women with COVID-19 in the pregnancy and postpartum period: a sequential, prospective meta-analysis
Emily Rose Smith et al. · American Journal of Obstetrics and Gynecology
Open access |
23 Aug 2022 |
137 |
| 24 |
Acceptability and use of a dapivirine vaginal ring in a phase III trial
Elizabeth Montgomery, Ariane van der Straten, Miria Chitukuta et al. · AIDS
Open access |
18 Mar 2017 |
137 |
| 25 |
Durable‐goods oligopoly with secondary markets: the case of automobiles
Susanna Esteban, Matthew Shum · The RAND Journal of Economics
Open access |
Jun 2007 |
133 |
| 26 |
Changes in preterm birth and stillbirth during COVID-19 lockdowns in 26 countries
Clara Calvert et al. · Nature Human Behaviour
Open access115 authors |
27 Feb 2023 |
126 |
| 27 |
Isoniazid Preventive Therapy in HIV-Infected Pregnant and Postpartum Women
Amita Gupta et al. · New England Journal of Medicine
Open access |
2 Oct 2019 |
125 |
| 28 |
Antiretroviral Concentrations in Breast-Feeding Infants of Mothers Receiving Highly Active Antiretroviral Therapy
Mark Mirochnick, Timothy K. Thomas, Edmund V. Capparelli et al. · Antimicrobial Agents and Chemotherapy
Open access |
30 Dec 2008 |
119 |
| 29 |
HIV-1 Drug Resistance Emergence among Breastfeeding Infants Born to HIV-Infected Mothers during a Single-Arm Trial of Triple-Antiretroviral Prophylaxis for Prevention of Mother-To-Child Transmission: A Secondary Analysis
Clement E. Zeh, Paul J. Weidle, Lillian Nafisa et al. · PLoS Medicine
Open access |
29 Mar 2011 |
116 |
| 30 |
Reducing the risk of mother-to-child human immunodeficiency virus transmission: past successes, current progress and challenges, and future directions
Mary Glenn Fowler, Margaret A. Lampe, Denise J. Jamieson et al. · American Journal of Obstetrics and Gynecology
|
Sep 2007 |
115 |
| 31 |
Elucidating Novel Serum Biomarkers Associated with Pulmonary Tuberculosis Treatment
Mary Ann De Groote, Payam Nahid, Leah G. Jarlsberg et al. · PLoS ONE
Open access |
18 Apr 2013 |
115 |
| 32 |
Daily Rifapentine for Treatment of Pulmonary Tuberculosis. A Randomized, Dose-Ranging Trial
Susan E. Dorman, Radojka M. Savić, STEFAN V. GOLDBERG et al. · American Journal of Respiratory and Critical Care Medicine
Open access |
9 Dec 2014 |
113 |
| 33 |
Safety, uptake, and use of a dapivirine vaginal ring for HIV-1 prevention in African women (HOPE): an open-label, extension study
Jared M. Baeten et al. · The Lancet HIV
Open access790 authors |
Feb 2021 |
112 |
| 34 |
Substitution of Rifapentine for Rifampin During Intensive Phase Treatment of Pulmonary Tuberculosis: Study 29 of the Tuberculosis Trials Consortium
Susan E. Dorman, STEFAN V. GOLDBERG, Jason E. Stout et al. · The Journal of Infectious Diseases
|
30 Jul 2012 |
110 |
| 35 |
Frequency of Gastroenteritis and Gastroenteritis-Associated Mortality With Early Weaning in HIV-1-Uninfected Children Born to HIV-Infected Women in Malawi
George Kafulafula, Donald R. Hoover, Taha E. Taha et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes
|
22 Dec 2009 |
103 |
| 36 |
Dolutegravir as First- or Second-Line Treatment for HIV-1 Infection in Children
Anna Turkova et al. · UCL Discovery (University College London)
|
30 Dec 2021 |
102 |
| 37 |
Growth, immune and viral responses in HIV infected African children receiving highly active antiretroviral therapy: a prospective cohort study
Philippa Musoke, Peter Mudiope, Linda Barlow‐Mosha et al. · BMC Pediatrics
Open access |
6 Aug 2010 |
99 |
| 38 |
Metabolic complications and treatment of perinatally HIV‐infected children and adolescents
Linda Barlow‐Mosha, Allison Ross Eckard, Grace A. McComsey et al. · Journal of the International AIDS Society
Open access |
2013 |
99 |
| 39 |
Sensitivity of direct versus concentrated sputum smear microscopy in HIV-infected patients suspected of having pulmonary tuberculosis
Adithya Cattamanchi, David W. Dowdy, J. Lucian Davis et al. · BMC Infectious Diseases
Open access |
6 May 2009 |
98 |
| 40 |
Contact Investigation for Active Tuberculosis Among Child Contacts in Uganda
Devan Jaganath, Sarah Zalwango, Brenda Okware et al. · Clinical Infectious Diseases
Open access |
27 Sep 2013 |
96 |
| 41 |
Effectiveness of the Standard WHO Recommended Retreatment Regimen (Category II) for Tuberculosis in Kampala, Uganda: A Prospective Cohort Study
Edward C. Jones‐López, Irene Ayakaka, Jonathan B. Levin et al. · PLoS Medicine
Open access |
15 Mar 2011 |
96 |
| 42 |
Evaluation of the Xpert MTB/RIF test for the diagnosis of childhood pulmonary tuberculosis in Uganda: a cross-sectional diagnostic study
Moorine Penninah Sekadde, Eric Wobudeya, Moses Lutaakome Joloba et al. · BMC Infectious Diseases
Open access |
12 Mar 2013 |
95 |
| 43 |
Infant human immunodeficiency virus diagnosis in resource-limited settings: issues, technologies, and country experiences
Tracy L Creek, Gayle Gillian Sherman, John N. Nkengasong et al. · American Journal of Obstetrics and Gynecology
Open access |
Sep 2007 |
94 |
| 44 |
Impact of Xpert MTB/RIF Testing on Tuberculosis Management and Outcomes in Hospitalized Patients in Uganda
Christina Yoon, Adithya Cattamanchi, J. Lucian Davis et al. · PLoS ONE
Open access |
6 Nov 2012 |
89 |
| 45 |
A Prospective Study of Community-Acquired Bloodstream Infections Among Febrile Adults Admitted to Mulago Hospital in Kampala, Uganda
Francis Ntengereze Ssali, Moses Robert Kamya, Fred Wabwire‐Mangen et al. · Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology
|
Dec 1998 |
89 |
| 46 |
Defining the optimal dose of rifapentine for pulmonary tuberculosis: Exposure–response relations from two phase II clinical trials
RM Savic, MARC H. WEINER, William R. Mac Kenzie et al. · Clinical Pharmacology & Therapeutics
Open access |
25 Jan 2017 |
88 |
| 47 |
Significant pharmacokinetic interactions between artemether/lumefantrine and efavirenz or nevirapine in HIV-infected Ugandan adults
Pauline Byakika‐Kibwika, Mohammed Lamorde, Jonathan Mayito et al. · Journal of Antimicrobial Chemotherapy
Open access |
11 Jun 2012 |
88 |
| 48 |
Neuropsychological performance in African children with HIV enrolled in a multisite antiretroviral clinical trial
Michael Joseph Boivin, Linda Barlow‐Mosha, Miriam C. Chernoff et al. · AIDS
Open access |
6 Nov 2017 |
87 |
| 49 |
Stated product formulation preferences for HIV pre‐exposure prophylaxis among women in the VOICE‐D (MTN‐003D) study
Ellen H. Luecke, Helen Cheng, Kubashni Woeber et al. · Journal of the International AIDS Society
Open access |
2016 |
86 |
| 50 |
Elucidating Emergence and Transmission of Multidrug-Resistant Tuberculosis in Treatment Experienced Patients by Whole Genome Sequencing
Taane Gregory Clark, Kim Mallard, Francesc Coll et al. · PLoS ONE
Open access |
11 Dec 2013 |
85 |